TUBULIN GENES AND DRUG RESISTANCE
TUBULIN GENES AND DRUG RESISTANCE
批准号:
2712742
负责人:
BRANIMIR I SIKIC
金额:
$22.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-05 至 2000-05-31
关键词:
breast neoplasms clinical research drug resistance gene expression human genetic material tag human subject laboratory mouse microtubules multidrug resistance mutant neoplasm /cancer chemotherapy neoplastic cell nonHodgkin's lymphoma nucleic acid sequence oligonucleotides ovary neoplasms paclitaxel phenotype polymerase chain reaction protein isoforms tissue /cell culture transfection tubulin vinca alkaloids western blottings
中文摘要
描述:(摘自研究者摘要)鉴于紫杉烷和
英文摘要
DESCRIPTION: (taken from investigator s abstract) Given that taxanes and
vinca alkaloids are substrates for the mdr1 gene product, P-glycoprotein
(Pgp), and given that Pgp is not expressed in all clinical tumor specimens,
the investigator postulates that other mechanisms of resistance to these
classes of drugs may be expressed. Tubulins are the targets of the taxanes
and vinca alkaloids. Accordingly, the goal of this revised application is
to explore other mechanisms of resistance to these agents, with a focus on
tubulin genes. In support of this idea, some cell lines selected for
resistance to taxol express altered beta-tubulin. The investigator
therefore postulates that alterations in tubulin isoform expression,
especially changes in relative abundance, are responsible for this form of
resistance, and proposes 4 specific aims to test this hypothesis: (1) to
determine tubulin isoform expression in non-MDR models of resistance to
tubulin-targeted cytotoxins in leukemia, breast and ovarian carcinoma; (2)to
study the effects of altered tubulin gene expression on drug sensitivity and
microtubule assembly dynamics in transfected cells; (3) to modulate drug
sensitivity by down-regulation of specific tubulin gene expression with
antisense constructs and oligonucleotides; and (4) to study tubulin isoform
expression in tumor specimens obtained from patients before and after
therapy with taxanes or vinca alkaloids.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
2002
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[S. Šale;Raphael K. Sung;P. Shen;Kristine M. Yu;Yan Wang;G. Duran;Jong-Hyeok Kim;T. Fojo;P. Oefner;B. Sikic]
通讯作者:
S. Šale;Raphael K. Sung;P. Shen;Kristine M. Yu;Yan Wang;G. Duran;Jong-Hyeok Kim;T. Fojo;P. Oefner;B. Sikic
Protocol Specific Research Support
-
批准号:8181144
-
项目类别:
-
资助金额:$9.6万
-
财政年份:2010
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Taxane Resistance in Breast and Ovarian Cancer Cells
-
批准号:7826596
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2007
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Taxane Resistance in Breast and Ovarian Cancer Cells
-
批准号:7656733
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2007
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Taxane Resistance in Breast and Ovarian Cancer Cells
-
批准号:7201927
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2007
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Taxane Resistance in Breast and Ovarian Cancer Cells
-
批准号:8074492
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2007
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Taxane Resistance in Breast and Ovarian Cancer Cells
-
批准号:7472325
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2007
-
负责人:BRANIMIR I SIKIC
-
依托单位:
STUDY OF OBLIMERSEN (GENASENSETM, G3139) IN ADVANCED MALIGNANCIES
-
批准号:7375227
-
项目类别:
-
资助金额:$1.11万
-
财政年份:2005
-
负责人:BRANIMIR I SIKIC
-
依托单位:
STUDY OF OBLIMERSEN IN COMBINATION WITH GEMCITABINE IN ADVANCED MALIGNANCIES
-
批准号:7202072
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2004
-
负责人:BRANIMIR I SIKIC
-
依托单位:
TREATMENT OF ADVANCED SOLID MALIGNANCIES
-
批准号:7202037
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2004
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Phase I Study: Weekly BMS-188797 Alone & with Carboplat
-
批准号:6980896
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Phase I Study of BMS-310705 Given Every Three Weeks
-
批准号:6980938
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2003
-
负责人:BRANIMIR I SIKIC
-
依托单位:
A Phase I Study of Oblimersen (Genasense TM, G3139)
-
批准号:6980962
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2003
-
负责人:BRANIMIR I SIKIC
-
依托单位:
A Phase I Study of ZD1839 (Iressa TM) with Oxaliplatin
-
批准号:6980918
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2003
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Regulation of the Human MDR1 Gene
-
批准号:6483913
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2002
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Regulation of the Human MDR1 Gene
-
批准号:6747695
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2002
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Regulation of the Human MDR1 Gene
-
批准号:6941204
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2002
-
负责人:BRANIMIR I SIKIC
-
依托单位:
Regulation of the Human MDR1 Gene
-
批准号:6626007
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2002
-
负责人:BRANIMIR I SIKIC
-
依托单位:
GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS
-
批准号:6514895
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2001
-
负责人:BRANIMIR I SIKIC
-
依托单位:
GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS
-
批准号:6291503
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2001
-
负责人:BRANIMIR I SIKIC
-
依托单位:
GENE EXPRESSION PROFILING OF UNKNOWN PRIMARY CANCERS
-
批准号:6656872
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2001
-
负责人:BRANIMIR I SIKIC
-
依托单位:
海外基金